Advertisement
Screener

Haemonetics Corporation (HAE) Goodwill, Foreign Currency Translation Gain (Loss)

2.6 / 5 stars · 48/93 Roast Me

Haemonetics Corporation Goodwill, Foreign Currency Translation Gain (Loss)

Haemonetics Corporation (HAE) reported Goodwill, Foreign Currency Translation Gain (Loss) of -$1.20 million for the 3-month period ending 2026-06-27, per its 10-Q filed 2026-08-06.

Financial Statements › Income Statement › Other Income

us-gaap:GoodwillForeignCurrencyTranslationGainLoss · last filed 2026-08-06

  • Haemonetics Corporation goodwill, foreign currency translation gain (loss) for the quarter ending 2026-06-27 was -$1.20M, a 139.54% decline year-over-year.
  • Haemonetics Corporation goodwill, foreign currency translation gain (loss) for the quarter ending 2026-03-28 was -$935.00K, a 202.86% decline year-over-year.
  • Haemonetics Corporation goodwill, foreign currency translation gain (loss) for the quarter ending 2025-12-27 was $724.00K.
  • Haemonetics Corporation goodwill, foreign currency translation gain (loss) for the quarter ending 2025-09-27 was -$1.20M, a 157.02% decline year-over-year.
  • Haemonetics Corporation goodwill, foreign currency translation gain (loss) for fiscal 2026 was $1.62M.
  • Haemonetics Corporation goodwill, foreign currency translation gain (loss) for fiscal 2025 was -$4.73M.
  • Haemonetics Corporation goodwill, foreign currency translation gain (loss) for fiscal 2024 was -$511.00K.
  • Haemonetics Corporation goodwill, foreign currency translation gain (loss) for fiscal 2023 was -$1.06M.
Period endGoodwill, Foreign Currency Translation Gain (Loss) 3 monthGoodwill, Foreign Currency Translation Gain (Loss) 6 monthGoodwill, Foreign Currency Translation Gain (Loss) 9 monthGoodwill, Foreign Currency Translation Gain (Loss) 12 monthGoodwill, Foreign Currency Translation Gain (Loss) 12 month as first filed
2026-06-27-$1.20M
10-Q · filed 2026-08-06
-$2.13M
derived: sum of 2 quarters · filed 2026-08-06
-$1.41M
derived: sum of 3 quarters · filed 2026-08-06
-$2.61M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-28-$935.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-20
-$211.00K
derived: sum of 2 quarters · filed 2026-05-20
-$1.41M
derived: sum of 3 quarters · filed 2026-05-20
$1.62M
10-K · filed 2026-05-20
2025-12-27$724.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-05
-$474.00K
derived: sum of 2 quarters · filed 2026-02-05
$2.56M
10-Q · filed 2026-02-05
$3.46M
derived: sum of 4 quarters · filed 2026-05-20
2025-09-27-$1.20M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-06
$1.83M
10-Q · filed 2025-11-06
$2.74M
derived: sum of 3 quarters · filed 2026-05-20
-$3.68M
derived: sum of 4 quarters · filed 2026-05-20
2025-06-28$3.03M
10-Q · filed 2025-08-07
$3.94M
derived: sum of 2 quarters · filed 2026-05-20
-$2.48M
derived: sum of 3 quarters · filed 2026-05-20
-$381.00K
derived: sum of 4 quarters · filed 2026-05-20
2025-03-29$909.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-20
-$5.51M
derived: sum of 2 quarters · filed 2026-05-20
-$3.41M
derived: sum of 3 quarters · filed 2026-05-20
-$4.73M
10-K · filed 2026-05-20
2024-12-28-$6.42M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-06
-$4.32M
derived: sum of 2 quarters · filed 2025-02-06
-$5.63M
10-Q · filed 2025-02-06
-$7.83M
derived: sum of 4 quarters · filed 2025-05-21
2024-09-28$2.10M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-07
$786.00K
10-Q · filed 2024-11-07
-$1.41M
derived: sum of 3 quarters · filed 2025-05-21
$1.10M
derived: sum of 4 quarters · filed 2025-05-21
2024-06-29-$1.31M
10-Q · filed 2024-08-08
-$3.52M
derived: sum of 2 quarters · filed 2025-05-21
-$1.00M
derived: sum of 3 quarters · filed 2025-05-21
2024-03-30-$2.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-21
$315.00K
derived: sum of 2 quarters · filed 2025-05-21
-$511.00K
10-K · filed 2025-05-21
2023-12-30$2.52M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-08
$1.69M
10-Q · filed 2024-02-08
2023-09-30-$826.00K
10-Q · filed 2023-11-02
2023-04-01-$1.06M
10-K · filed 2024-05-20
2022-04-02-$1.23M
10-K · filed 2023-05-22
2021-04-03$1.04M
10-K · filed 2022-05-25
2020-03-28-$410.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-05-26
-$389.00K
derived: sum of 2 quarters · filed 2021-05-26
-$488.00K
derived: sum of 3 quarters · filed 2021-05-26
-$167.00K
10-K · filed 2021-05-26
2019-12-28$21.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-04
-$78.00K
derived: sum of 2 quarters · filed 2020-02-04
$243.00K
10-Q · filed 2020-02-04
2019-09-28-$99.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-01
$222.00K
10-Q · filed 2019-11-01
2019-06-29$321.00K
10-Q · filed 2019-08-06
2019-03-30-$576.00K
10-K · filed 2020-05-20
2018-03-31$554.00K
10-K · filed 2019-05-22
2017-04-01-$10.00K
10-K · filed 2018-05-23
2016-04-02-$165.00K
10-K · filed 2017-05-24
$165.00K
10-K · filed 2016-06-01
2015-03-28$2.46M
10-K · filed 2016-06-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
TELEFLEX INC (TFX)United States$5.093B-5.44
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
Heartflow, Inc. (HTFL)United States$4.225B
ICU MEDICAL INC/DE (ICUI)United States$4.153B18.85
MiniMed Group, Inc. (MMED)United States$5.748B-16.85
PULSE BIOSCIENCES, INC. (PLSE)United States$3.696B-24.47
iRhythm Holdings, Inc. (IRTC)United States$3.651B-281.06
AtriCure, Inc. (ATRC)United States$3.089B
UFP TECHNOLOGIES INC (UFPT)United States$2.308B28.37
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55